ArticleCureus2025
Can the Nottingham Hip Fracture Score Predict Total Hip Replacement Versus Hemiarthroplasty Candidates?
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe choice between total hip replacement (THR) and hemiarthroplasty in displaced intracapsular hip fractures remains debated. Procedure selection can be difficult given the current evidence. Using the Nottingham Hip Fracture Score (NHFS), we aimed to introduce objectivity into decision-making.
methodsThis is a retrospective single-centre review (2019-2023) of 1210 patients undergoing THR (n=228) or hemiarthroplasty (n=982). NHFS was calculated for all patients in this time period. Outcomes included one‑year mortality and discharge destination, with subgroup analysis of NHFS 4-6 and patients aged >80 with NHFS 4-6. Statistical analysis was completed using IBM SPSS Statistics for Windows, Version 28.0 (IBM Corp., Armonk, New York, United States). Results: Hemiarthroplasty patients were older (82.2 vs. 74.6 years) and had higher mean NHFS (6.0 vs. 3.5) and higher one‑year mortality (36.2% vs. 3.5%). In the overall cohort, THR patients were more likely to be discharged home (65% vs. 39%), while hemiarthroplasty patients were more often discharged to institutional care. In the NHFS 4-6 subgroup, THR patients had lower mortality (3.4% vs. 29.6%; p<0.05) and more frequent home discharge (77.7% vs. 43.9%). In patients over 80 with NHFS 4-6, THR was associated with lower one-year mortality (4.2% vs. 13.8%) and a higher likelihood of independent living at home (75% vs. 60.9%) compared with hemiarthroplasty, although differences did not reach statistical significance.
conclusionHemiarthroplasty patients are older and have higher mortality. Within NHFS 4-6 and in some circumstances, THR was associated with lower mortality and more favourable discharge outcomes. NHFS may complement the National Institute for Health and Care Excellence (NICE) guidance in identifying candidates most likely to benefit from THR vs. hip hemiarthroplasty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.